D.E. Shaw & Co
RXST icon

D.E. Shaw & Co’s RxSight RXST Stock Holding History

D.E. Shaw & Co’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
1,959,732
+75,903
+4% +$630K 0.01% 1488
2025
Q4 		$19.6M Buy
1,883,829
+49,938
+3% +$501K 0.01% 1253
2025
Q3 		$16.5M Buy
1,833,891
+512,561
+39% +$4.5M 0.01% 1316
2025
Q2 		$17.2M Buy
1,321,330
+1,299,330
+5,906% +$19.5M 0.01% 1129
2025
Q1 		$556K Buy
22,000
+12,430
+130% +$369K ﹤0.01% 3449
2024
Q4 		$329K Sell
9,570
-92,821
-91% -$4.19M ﹤0.01% 3845
2024
Q3 		$5.06M Sell
102,391
-172,447
-63% -$8.84M ﹤0.01% 1934
2024
Q2 		$16.5M Sell
274,838
-68,142
-20% -$3.89M 0.02% 1013
2024
Q1 		$17.7M Buy
342,980
+144,410
+73% +$7.09M 0.02% 991
2023
Q4 		$8.01M Buy
198,570
+110,283
+125% +$3.23M 0.01% 1532
2023
Q3 		$2.46M Sell
88,287
-47,209
-35% -$1.41M ﹤0.01% 2407
2023
Q2 		$3.9M Buy
+135,496
New +$3.01M ﹤0.01% 2059

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co's RXST Position: Q1 2026 in Review

D.E. Shaw & Co increased its RxSight (RXST) stake by 4% in Q1 2026, buying an estimated $630K and bringing the position to 1,959,732 shares worth $12.1M. The position accounts for 0.01% of the portfolio, ranked #1488.

D.E. Shaw & Co first reported a position in RXST in Q2 2023 and has held it in 12 quarters since. The position peaked at $19.6M in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • D.E. Shaw & Co held 1,959,732 shares of RxSight worth $12.1M as of Q1 2026.
  • D.E. Shaw & Co bought 75,903 RxSight shares in Q1 2026, an estimated $630K.
  • RxSight made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1488 holding.
  • D.E. Shaw & Co first reported a position in RxSight in Q2 2023 and has held it in 12 quarters since.
  • D.E. Shaw & Co's RxSight position peaked at $19.6M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.